The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
March 2023
A debate on the future of transcatheter mitral valve replacement; a new ESC/EAPCI clinical consensus statement on renal denervation; a minifocus on interventional pharmacology; ticagrelor and prasugrel vs clopidogrel in patients who have undergone PCI for chronic coronary syndromes; the effects of evolocumab on platelet reactivity from the POMPEII registry: pharmacodynamic effects of cangrelor in patients with acute or chronic coronary syndrome undergoing PCI; a periprocedural bolus of cangrelor for comatose survivors of out-of-hospital cardiac arrest undergoing PCI and target temperature management; impact of non-fatal periprocedural major adverse events on ten-year mortality; pathologic responses to abluminal biodegradable versus circumferential durable polymer-coated DES; and more…
In this issue of EuroIntervention
Debate
Debate
Transcatheter mitral valve replacement will remain a niche therapy: pros and cons
March 20, 2023 | 10.4244/EIJ-E-22-00044
Interventions for hypertension and stroke
Expert consensus
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Barbato E,
Azizi M,
Schmieder RE,
Lauder L,
Böhm M,
Brouwers S,
Bruno RM,
Dudek D,
Kahan T,
Kandzari D,
Lüscher T,
Parati G,
Pathak A,
Ribichini F,
Schlaich M,
Sharp A,
Sudano I,
Volpe M,
Tsioufis C,
Wijns W,
Mahfoud F
March 20, 2023 | 10.4244/EIJ-D-22-00723
Coronary interventions - Mini focus on interventional pharmacology
Clinical research
Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes
Koshy A,
Giustino G,
Sartori S,
Hooda A,
Feng Y,
Snyder C,
Dasgupta S,
Kumar K,
Krishnamoorthy-Melarcode P,
Sweeny J,
Khera S,
Serrao G,
Sharma R,
Dangas G,
Kini A,
Mehran R,
Sharma S
March 20, 2023 | 10.4244/EIJ-D-22-00654
Editorial comment
Clopidogrel: still king of the ring for elective percutaneous coronary intervention!
March 20, 2023 | 10.4244/EIJ-E-23-00003
Clinical research
Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study
Franchi F,
Ortega-Paz L,
Rollini F,
Been L,
Rivas A,
Maaliki N,
Zhou X,
Pineda A,
Suryadevara S,
Soffer D,
Zenni M,
Angiolillo D
March 20, 2023 | 10.4244/EIJ-D-22-00719
Editorial comment
Effects of PCSK9 inhibitors on platelet function
March 20, 2023 | 10.4244/EIJ-E-23-00005
Research correspondence
Pharmacodynamic effects of cangrelor in elective complex PCI: insights from the POMPEII Registry
Gargiulo G,
Marenna A,
Sperandeo L,
Manzi L,
Avvedimento M,
Simonetti F,
Canonico M,
Paolillo R,
Spinelli A,
Borgia F,
Diserafino L,
Franzone A,
Stabile E,
Piccolo R,
Cirillo P,
Valgimigli M,
Esposito G
March 20, 2023 | 10.4244/EIJ-D-22-00594
Research correspondence
Cangrelor for comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention: the CANGRELOR-OHCA study
March 20, 2023 | 10.4244/EIJ-D-22-00675
Coronary interventions
Clinical research
Impact of periprocedural major adverse events on 10-year mortality after revascularisation
Kotoku N,
Serruys P,
Ninomiya K,
Soo A,
Masuda S,
Kageyama S,
Revaiah P,
Mack M,
Holmes DR,
Morice M,
Davierwala P,
Mohr F,
Milojevic M,
Kappetein A,
Garg S,
Onuma Y
March 20, 2023 | 10.4244/EIJ-D-22-00681
Editorial comment
Revascularisation, periprocedural events and survival – and the survival of the randomised controlled trial
March 20, 2023 | 10.4244/EIJ-E-23-00004
Editorial comment
Periprocedural adverse events after revascularisation: the importance of getting off to a good start
March 20, 2023 | 10.4244/EIJ-E-22-00054
Translational research
Early vascular responses to abluminal biodegradable polymer-coated versus circumferential durable polymer-coated newer-generation drug-eluting stents in humans: a pathological study
Kawagoe Y,
Otsuka F,
Onozuka D,
Ishibashi-Ueda H,
Ikeda Y,
Ohta-Ogo K,
Matsumoto M,
Amemiya K,
Asaumi Y,
Kataoka Y,
Nishimura K,
Miyamoto Y,
Noguchi T,
Finn A,
Virmani R,
Hatakeyama K,
Yasuda S
March 20, 2023 | 10.4244/EIJ-D-22-00650
Letter to the editor
Letter to the editor
Letter: Coronary physiology in severe aortic stenosis: solely a matter of increased coronary resting flow?
March 20, 2023 | 10.4244/EIJ-D-22-00998
Reply to the letter to the editor
Reply: Coronary physiology in severe aortic stenosis: solely a matter of increased coronary resting flow?
March 20, 2023 | 10.4244/EIJ-D-22-01031